Business Description
Stereotaxis Inc
NAICS : 334510
SIC : 3845
ISIN : US85916J4094
Total Employee Number:
131Description
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.77 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.26 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -12.78 | |||||
Beneish M-Score | -2.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.3 | |||||
3-Year EBITDA Growth Rate | 2.1 | |||||
3-Year EPS without NRI Growth Rate | 1.3 | |||||
3-Year FCF Growth Rate | -2.1 | |||||
3-Year Book Growth Rate | -26.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 37.29 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.96 | |||||
9-Day RSI | 43.54 | |||||
14-Day RSI | 45.16 | |||||
3-1 Month Momentum % | -4.06 | |||||
6-1 Month Momentum % | -27.78 | |||||
12-1 Month Momentum % | -14.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 251.7 | |||||
Days Sales Outstanding | 58.97 | |||||
Days Payable | 139.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.4 | |||||
Shareholder Yield % | -11.92 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.86 | |||||
Operating Margin % | -71.05 | |||||
Net Margin % | -69.5 | |||||
EBITDA Margin % | -65.99 | |||||
FCF Margin % | -49.44 | |||||
OCF Margin % | -49.18 | |||||
ROE % | -167.34 | |||||
ROA % | -45.41 | |||||
ROIC % | -67.98 | |||||
3-Year ROIIC % | -29.77 | |||||
ROC (Joel Greenblatt) % | -269.4 | |||||
ROCE % | -86.61 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.07 | |||||
PB Ratio | 11.56 | |||||
Price-to-Tangible-Book | 37.05 | |||||
EV-to-EBIT | -7.44 | |||||
EV-to-EBITDA | -8.01 | |||||
EV-to-Revenue | 5.29 | |||||
EV-to-Forward-Revenue | 4.43 | |||||
EV-to-FCF | -10.69 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Median-PS-Value | 0.89 | |||||
Earnings Yield (Greenblatt) % | -13.44 | |||||
FCF Yield % | -9.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stereotaxis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 26.809 | ||
| EPS (TTM) (€) | -0.206 | ||
| Beta | 0.8596 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.36 | ||
| Volatility % | 42.41 | ||
| 14-Day RSI | 45.16 | ||
| 14-Day ATR (€) | 0.040457 | ||
| 20-Day SMA (€) | 1.5196 | ||
| 12-1 Month Momentum % | -14.75 | ||
| 52-Week Range (€) | 1.386 - 3 | ||
| Shares Outstanding (Mil) | 99.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stereotaxis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stereotaxis Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 16:30 | In 123 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 16:30 | In 27 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 26 days | ||
| General meeting for 2026 | 2026-05-15 10:00 | 1.55 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 16:30 | 1.57 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 1.57 (+0.00%) | ||
| Robocath Acquisition | 2026-04-15 09:00 | 1.59 (+0.00%) | ||
| Annual report for 2025 | 2026-03-13 | 1.62 (+1.89%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-09 16:30 | 1.85 (+0.00%) |
Show
Entries
Stereotaxis Inc Frequently Asked Questions
What is Stereotaxis Inc(FRA:RJR1)'s stock price today?
The current price of FRA:RJR1 is €1.48. The 52 week high of FRA:RJR1 is €3.00 and 52 week low is €1.39.
When is next earnings date of Stereotaxis Inc(FRA:RJR1)?
The next earnings date of Stereotaxis Inc(FRA:RJR1) is 2026-08-07 Est..
Does Stereotaxis Inc(FRA:RJR1) pay dividends? If so, how much?
Stereotaxis Inc(FRA:RJR1) does not pay dividend.
Press Release
Articles on Stereotaxis Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers